Shorla names new chief commercial officer

Shorla Pharma Ltd. hired Rayna Herman as chief commercial officer. Herman was CCO at Eversana Life Science Services LLC, a commercialization services company. Shorla worked with Eversana to launch its first product, nelarabine injection to treat T cell acute lymphoblastic leukemia and T cell lymphoblastic lymphoma. FDA approved the drug in March. 

Santhera Pharmaceuticals Holding AG (SIX:SANN) promoted Geert Jan van Daal to CCO and Marc Schrader to CTO, effective Jan. 1. Van Daal has held several roles at the company for almost nine years, most recently as head of European affiliates and EU market access. Schrader joined in 2022 as head of technical development and operations...